A0A663DHG4 (A0A663DHG4_PANTR) Pan troglodytes (Chimpanzee)
Tumor necrosis factor UniProtKBInterProInteractive Modelling
233 aa; Sequence (Fasta) ;
5 identical sequences: Homo sapiens: P01375, Q5STB3; Pan troglodytes: A0A0U5J3S4; Pan paniscus: A0A2R8ZGR1; Gorilla gorilla gorilla: G3QT76
Available Structures
43 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human TNF-alpha TNFR1 complex bound to conformationally selective antibody |
Heteromer P01375; P19438; | 100 | 9×GOL; 1×D84; 1×NAG; | |||
| Crystal structure of the human tumor necrosis factor in complex with golimumab Fv |
Heteromer P01375; | 100 | ||||
| Crystal structure of TNF alpha complexed with a poxvirus MHC-related TNF binding protein |
Heteromer P01375; Q9DHW0; | 99.34 | 9×NAG; | |||
| Crystal structure of TNFalpha in complex with Adalimumab Fab fragment |
Heteromer P01375; | 99.34 | ||||
| Complex between human TNF alpha and Llama VHH3 |
Heteromer P01375; | 100.0 | ||||
| Trimer-to-Monomer Disruption of Tumor Necrosis Factor-alpha (TNF-alpha) by unnatural alpha/beta-pep… |
Heteromer P01375; | 100.0 | 3×EDO; 1×NH2; | |||
| Trimer-to-Monomer Disruption of Tumor Necrosis Factor-alpha (TNF-alpha) by alpha-peptide-3 |
Heteromer P01375; | 100.0 | ||||
| Crystal structure of human TNF alpha in complex with TNF30(VHH) domain of ozoralizumab |
Heteromer P01375; | 100.0 | ||||
| Selection of a novel highly specific TNFalpha antagonist: Insight from the crystal structure of the… |
Heteromer P01375; P05452; | 100 | 1×MG; | |||
| TNFalpha-certolizumab Fab |
Heteromer P01375; | 100.0 | ||||
| Crystal structure of TNF-TNFR2 complex |
Heteromer P01375; P20333; | 95.75 | 3×CO; | |||
| Structure of human Tumor Necrosis Factor (TNF) in complex with the Llama VHH1 |
Heteromer P01375; | 100 | ||||
| Crystal structure of TNF-alpha in complex with Infliximab Fab fragment |
Heteromer P01375; | 100 | ||||
| Human SIRT2 in complex with myristoylated peptide (TNF-alphaK20myr) |
Heteromer P01375; Q8IXJ6; | 85.71 | 1×ZN; | |||
| CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR | homo-6-mer | 98.67 | ||||
| Crystal Structure of TNF-alpha with a small molecule inhibitor | homo-4-mer | 100.0 | 2×307; | |||
| HUMAN TNF-ALPHA IN COMPLEX WITH 2-[5-(3-chloro-4-{[(1R)-1-(2-fluorophenyl)ethyl]amino}quinolin-6-yl… | homo-3-mer | 100 | 1×VGY; 1×GOL; | |||
| asymmetric hTNF-alpha | homo-3-mer | 100.0 | 1×A7G; | |||
| TUMOR NECROSIS FACTOR ALPHA, R31D MUTANT | homo-3-mer | 99.34 | ||||
| asymmetric hTNF-alpha | homo-3-mer | 100.0 | 1×D84; | |||
| THE STRUCTURE OF TUMOR NECROSIS FACTOR-ALPHA AT 2.6 ANGSTROMS RESOLUTION. IMPLICATIONS FOR RECEPTOR… | homo-3-mer | 99.34 | ||||
| Asymmetric hTNF-alpha | homo-3-mer | 100.0 | 1×CL; 1×A6Y; | |||
| Asymmetric hTNF-alpha | homo-3-mer | 100.0 | 1×MRD; 1×A7M; | |||
| TNFR1 selectve TNF mutant; R1-6 | homo-3-mer | 92.25 | 1×GOL; | |||
| Asymmetric hTNF-alpha | homo-3-mer | 100.0 | 1×A7A; | |||
| Crystal Structure of TNFalpha with indolinone compound 9 | homo-3-mer | 100.0 | 1×UTV; | |||
| Crystal Structure of TNFalpha with indolinone compound 11 | homo-3-mer | 100 | 1×UTY; | |||
| TNF Receptor Subtype One-selective TNF Mutant with Antagonistic Activity | homo-3-mer | 92.0 | ||||
| Crystal Structure of TNFalpha with isoquinoline compound 4 | homo-3-mer | 100.0 | 1×UTM; | |||
| Crystal Structure of TNFalpha with isoquinoline compound 2 | homo-3-mer | 100.0 | 2×UTJ; | |||
| TNF Receptor Subtype One-selective TNF Mutant with Antagonistic Activity; R1antTNF-T8 | homo-3-mer | 91.55 | ||||
| Crystal Structure of Spin-Labeled T77C TNFa | homo-3-mer | 99.25 | 3×MTN; | |||
| Complex between human TNF alpha and Llama VHH2 | homo-3-mer | 100.0 | ||||
| HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT | homo-3-mer | 97.99 | ||||
| Crystal structure of human NGR-TNF | homo-3-mer | 100 | ||||
| Crystal Structure of TNFalpha with fragment compound 6 | homo-3-mer | 100.0 | 2×UTS; | |||
| HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT | homo-3-mer | 97.97 | ||||
| Human TNFa dimer in complex with the semi-synthetic bicyclic peptide M21 | homo-2-mer | 100 | 4×GOL; 1×38A; | |||
| HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525 | homo-2-mer | 100.0 | 2×JNI; | |||
| Transmembrane helix of tumor necrosis factor alpha in trifluorethanol, S34P mutant | monomer | 96.97 | ||||
| Transmembrane helix of tumor necrosis factor alpha in trifluorethanol | monomer | 100 | ||||
| Transmembrane helix of tumor necrosis factor alpha in trifluorethanol, AGALLL mutant | monomer | 90.91 | ||||
| Conformational ensemble of solnatide in solution | monomer | 100 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2e7a.1.A | homo-3-mer | 0.80 | 92.36 | |||
| 7usy.1.F | monomer | 0.51 | 13.16 | |||
| 7asy.1.A | monomer | 0.50 | 100.00 | |||